Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-22

Clinical Trial Update: Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for sulodexide in chronic venous disease of the lower extremities is underway, with current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulodexide (sulodexide)

Snippet

Sponsor: Value Outcomes Ltd. | Conditions: Chronic Venous Disease, Chronic Insufficiency Venous | Phase 3 | Status: UNKNOWN